PANDAS: IT’S NOT SO BLACK AND WHITE
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1 NAPNAP contact hour, of which 0.25 is pharmacology.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: email@example.com
Copyright 2018 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
• List the major and minor criteria for PANDAS diagnosis.
• Review how to start treatment for PANDAS in the primary setting.
• Identify laboratory tests that can assist in making the diagnosis and treatment plan.
Jennifer Gagnon, MSN, CPNP, FNP-C, Nurse Practitioner, Latimer Neurology Center, Washington
None to Report
Jennifer Gagnon reported the below pharmaceuticals and/or medical devices that may be discussed for off-label use:
bio-therapeutic agents (Rituxamib), antibiotics (macrolides, sulfonamides, penicillin and cephalosporins), IVIG
- 1.00 Contact hours